ASCO 2022 Updates in HR+/HER2- eBC
ASCO 2022 on ABCSG-18 Trial: Long-Term Outcomes of Adjuvant Denosumab in Breast Cancer: Fracture Reduction & Survival Results
By
ASCO 2022 Conference Coverage
FEATURING
Michael Gnant
By
ASCO 2022 Conference Coverage
FEATURING
Michael Gnant
Login to view comments.
Click here to Login
ASCO 2022 Updates in HR+/HER2- eBC